Steve Schonfeld’s Assembly Biosciences ASMB Stock Holding History

Steve Schonfeld’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.65M	Buy	242,153 +121,653	+101%	+$3.31M	0.02%	543
2026 Q1	$3.34M	Buy	120,500 +66,265	+122%	+$1.89M	0.02%	619
2025 Q4	$1.84M	Sell	54,235 -67,653	-56%	-$2.18M	0.01%	903
2025 Q3	$3.12M	Buy	+121,888	New	+$2.67M	0.02%	815
2021 Q1	–	Sell	-24,989	Closed	-$1.81M	–	1779
2020 Q4	$1.81M	Buy	+24,989	New	+$2.93M	0.02%	621
2020 Q1	–	Sell	-2,999	Closed	-$736K	–	1130
2019 Q4	$736K	Buy	+2,999	New	+$552K	0.02%	598
2019 Q1	–	Sell	-2,567	Closed	-$697K	–	1041
2018 Q4	$697K	Sell	2,567 -1,066	-29%	-$308K	0.03%	561
2018 Q3	$1.62M	Sell	3,633 -200	-5%	-$93.7K	0.07%	332
2018 Q2	$1.8M	Buy	3,833 +2,638	+221%	+$1.39M	0.1%	287
2018 Q1	$704K	Buy	+1,195	New	+$741K	0.05%	402

Other funds holding ASMB

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Steve Schonfeld's ASMB Position: Q2 2026 in Review

Steve Schonfeld increased its Assembly Biosciences (ASMB) stake by 101% in Q2 2026, buying an estimated $3.31M and bringing the position to 242,153 shares worth $6.65M. The position accounts for 0.02% of the portfolio, ranked #543.

Steve Schonfeld first reported a position in ASMB in Q1 2018 and has held it in 10 quarters since. 92 funds tracked by Wall St. Rank hold ASMB as of Q2 2026.

Steve Schonfeld held 242,153 shares of Assembly Biosciences worth $6.65M as of Q2 2026.
Steve Schonfeld bought 121,653 Assembly Biosciences shares in Q2 2026, an estimated $3.31M.
Assembly Biosciences made up 0.02% of Steve Schonfeld's portfolio in Q2 2026, its #543 holding.
Steve Schonfeld first reported a position in Assembly Biosciences in Q1 2018 and has held it in 10 quarters since.
92 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.